DDMAC's Expanding Catalog Of Studies
You may also be interested in...
Census Delays Planned DDMAC Studies On Various Aspects Of DTC Advertising
FDA's ability to conduct studies of direct-to-consumer advertising is being impacted by the 2010 census, slowing two pending FDA studies just as the agency is preparing to start three more
“Brief Summary” Format Changes: FDA Gets Proof of Principle In First Study
FDA will narrow the focus of subsequent studies examining the "brief summary" of risk information in print drug ads to focus on one medical condition following preliminary results from the first study, which considered three different conditions
FDA Advertising Oversight Will Consider Impact Of “Puppies” And The Internet
FDA is pushing forward several research initiatives to help better define how print and broadcast direct-to-consumer ads should be structured, but the agency is adopting a less formal approach to oversight of Internet advertising